Cell (iPSC ES CAR-T MSC NK) Process Development And Optimization For Commercial Manufacturing CDMO Services

Source: CCRM
t-cell attacking cancer 450x300

CCRM has deep experience in optimizing and developing processes for various cell types to ensure success during cGMP manufacturing. One example is the CAR-T process developed for a key international client, which is now being used to treat patients in clinical trials and with initial positive outcomes.

  • CCRM has developed next-generation CAR-T processes (e.g. serum-free, automated, closed); collaboration with Cytiva (formerly GE Life Sciences) allows us to leverage FlexFactory offering to enable expansion of client-site capacity
  • CCRM has rapidly generated data to support IND filings under accelerated timelines

Need More Information? Just Ask.

Click the button below to directly contact the supplier. Use it to:

  • Ask a question.
  • Request more detailed information or literature.
  • Discuss your current project/application.
  • Request a quote.
  • Locate a distributor in your area.
  • Schedule a demo.
Request Information